Thymosin alpha-1
Showing 1 - 25 of >10,000
NSCLC Trial in Guangzhou (Hypofractionated radiotherapy, induction chemo-immunotherapy, concurrent chemo)
Recruiting
- Non-small Cell Lung Cancer
- Hypofractionated radiotherapy
- +4 more
-
Guangzhou, Guangdong, ChinaSun yat-sen university cancer center
Nov 14, 2023
Rheumatic Heart Disease, Cardiopulmonary Bypass, Immunotherapy Trial in Nanjing (Thymosin Alpha1, Blank Control)
Recruiting
- Rheumatic Heart Disease
- +2 more
- Thymosin Alpha1
- Blank Control
-
Nanjing, Jiangsu, ChinaThe first affiliated hospital of nanjing medical university
Aug 3, 2022
Acute Aortic Syndrome, Aortic Dissectio Trial in Nanjing, Beijing (Thymosin Alpha1, 28A-Glycine-28B-L-Arginine-28C-L-Glutamic
Recruiting
- Acute Aortic Syndrome
- Aortic Dissectio
- Thymosin Alpha1, 28A-Glycine-28B-L-Arginine-28C-L-Glutamic Acid-28D-L-Alanine-28E-L-Proline-28F-L-Alanine-28G-L-Asparagine-
- Blank control
-
Nanjing, Jiangsu, China
- +2 more
Sep 25, 2022
Stage II Colorectal Cancer, Stage III Colorectal Cancer Trial in Shanghai (Thymosin Alpha1)
Recruiting
- Stage II Colorectal Cancer
- Stage III Colorectal Cancer
- Thymosin Alpha1
-
Shanghai, Shanghai, ChinaZhongshan Hospital, Fudan University
Oct 7, 2021
Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Thymalfasin, Radiotherapy, PD-1/PD-L1 inhibitor)
Recruiting
- Advanced Solid Tumor
- Refractory Tumor
- Thymalfasin
- +3 more
-
Suzhou, ChinaThe Second Affiliated Hospital of SchoowUniversity
Mar 29, 2023
Long-term Effects of Thymosin Alpha 1 Treatment Trial (Thymosin Alpha1)
Not yet recruiting
- Long-term Effects of Thymosin Alpha 1 Treatment
- Thymosin Alpha1
- (no location specified)
May 24, 2021
NSCLC Trial in Guangzhou (Concurrent chemo, split-course radiotherapy, thymosin alpha 1)
Completed
- Non-small Cell Lung Cancer
- Concurrent chemotherapy
- +2 more
-
Guangzhou, Guangdong, ChinaSun yat-sen University Cancer Center
Dec 30, 2021
Pancreatitis, Acute Necrotizing Trial in Nanjing (Thymosin Alpha 1, normal saline)
Completed
- Pancreatitis, Acute Necrotizing
- Thymosin Alpha 1
- normal saline
-
Nanjing, Jiangsu, China
- +1 more
Apr 1, 2021
Osteoporotic Pain Trial in Shanghai (Thymosin Alpha1)
Unknown status
- Osteoporotic Pain
- Thymosin Alpha1
-
Shanghai, Shanghai, ChinaDiansan Su
Aug 24, 2020
2019 Novel Coronavirus Infection Trial in Shiyan (recombinant human interferon Alpha-1b, thymosin alpha 1)
Unknown status
- 2019 Novel Coronavirus Infection
- recombinant human interferon Alpha-1b
- thymosin alpha 1
-
Shiyan, Hubei, ChinaTaihe Hospital
Mar 30, 2020
Thymoma and Thymic Carcinoma Trial in Guangzhou (Thymosin a1, hypofractionated radiotherapy, concurrent chemoradiotherapy)
Active, not recruiting
- Thymoma and Thymic Carcinoma
- Thymosin a1
- +2 more
-
Guangzhou, Guangdong, ChinaSun yat-sen University Cancer Center
Nov 27, 2021
Acute Respiratory Distress Syndrome Trial in China (device, behavioral, drug, other, biological, combination product, genetic)
Recruiting
- Acute Respiratory Distress Syndrome
- protective ventilation
- +13 more
-
Beijing, China
- +10 more
Dec 13, 2022
Solid Tumor Trial (Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T), Tumor necrosis factor-thymosin alfa 1 recombinant
Completed
- Solid Tumor
- Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T)
- Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T) and chemotherapy
- (no location specified)
Jun 8, 2023
Alpha-1 Antitrypsin Deficiency Trial in Gainesville (Alpha-1 Antitrypsin Genotype)
Recruiting
- Alpha-1 Antitrypsin Deficiency
- Alpha-1 Antitrypsin Genotype
-
Gainesville, FloridaUniversity of Florida
Nov 2, 2022
Alpha 1-Antitrypsin Deficiency Trial in Charleston (KB408 (Nebulization))
Not yet recruiting
- Alpha 1-Antitrypsin Deficiency
- KB408 (Nebulization)
-
Charleston, South CarolinaMedical University of South Carolina
Sep 20, 2023
Alpha-1 Antitrypsin Deficiency Trial in San Diego, Boston, Saint Louis (Liver Biopsy (Biopsy Group Only))
Recruiting
- Alpha-1 Antitrypsin Deficiency
- Liver Biopsy (Biopsy Group Only)
-
San Diego, California
- +2 more
Dec 13, 2022
DiabetesType 1 Trial (Placebo, Alpha Lipoic Acid 600 MG Oral Capsule)
Not yet recruiting
- Diabetes MellitusType 1
- Placebo
- Alpha Lipoic Acid 600 MG Oral Capsule
- (no location specified)
Jan 8, 2023
Alpha1-Antitrypsin Deficiency Trial in United States (Alpha-1 15%, Liquid Alpha1-Proteinase Inhibitor (Human))
Recruiting
- Alpha1-Antitrypsin Deficiency
- Alpha-1 15%
- Liquid Alpha1-Proteinase Inhibitor (Human)
-
Gainesville, Florida
- +5 more
Jan 13, 2023
Alpha1-Antitrypsin Deficiency Trial (Fazirsiran Injection)
Not yet recruiting
- Alpha1-Antitrypsin Deficiency
- Fazirsiran Injection
- (no location specified)
Jun 16, 2023
Alpha-1 Foundation DNA and Tissue Bank
Enrolling by invitation
- Alpha 1 Antitrypsin Deficiency
-
Gainesville, FloridaUniversity of Florida
Sep 19, 2022
Cardiac Functions in Type 1 Diabetes Mellitus
Not yet recruiting
- Diabetes Mellitus, Type 1
- +2 more
- transthoracic echocardiography
- (no location specified)
Nov 12, 2023
Type1diabetes, Hypoglycemia, Type 1 Diabetes Trial in Hellerup (Infusion of GIP[1-42], GIP[1-30] or )
Recruiting
- Type1diabetes
- +2 more
- Infusion of GIP[1-42], GIP[1-30] or placebo
-
Hellerup, Copenhagen, DenmarkCenter for Clinical Metabolic Research, Gentofte Hospital
Nov 17, 2023
Bronchiectasis Adult Trial in Dundee (Alpha 1-Proteinase Inhibitor 180mg/kg, Alpha 1-Proteinase Inhibitor 120mg/kg, Sodium
Not yet recruiting
- Bronchiectasis Adult
- Alpha 1-Proteinase Inhibitor 180mg/kg
- +2 more
-
Dundee, United KingdomNHS Tayside
Oct 12, 2022